Since CREB knockdown decreased AML cell growth, but not that of normal hematopoietic cells in transplantation assays, we wished to test whether these putative CREB-inhibiting compounds were also non-toxic to normal hematopoietic cells. This evidence concerns the gene CREB1 and acute myeloid leukemia.